BALCHEM CORP
For the period ended Dec 31, 2024. Filed Feb 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 21, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURE PAGE
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: February 21, 2025 | BALCHEM CORPORATION |
|---|---|
| By:/s/ Theodore L. Harris | |
| Theodore L. Harris, Chairman, President and | |
| and Chief Executive Officer |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
/s/ Theodore L. Harris
Theodore L. Harris, Chairman, President and
Chief Executive Officer
Date: February 21, 2025
/s/ C. Martin Bengtsson
C. Martin Bengtsson, Executive Vice President and
Chief Financial Officer
Date: February 21, 2025
/s/ William A. Backus
William A. Backus, Vice President and
Chief Accounting Officer
Date: February 21, 2025
/s/ David B. Fischer
David B. Fischer, Director
Date: February 21, 2025
/s/ Kathleen B. Fish
Kathleen B. Fish, Director
Date: February 21, 2025
/s/ Daniel E. Knutson
Daniel E. Knutson, Director
Date: February 21, 2025
/s/ Olivier Rigaud
Olivier Rigaud, Director
Date: February 21, 2025
/s/ Monica Vicente
Monica Vicente, Director
Date: February 21, 2025
/s/ Matthew D. Wineinger
Matthew D. Wineinger, Director
Date: February 21, 2025
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.